Abstract
Potential treatments for coronavirus disease 2019 (COVID-19) are being investigated at unprecedented speed, and successful treatments will rapidly be used in tens or hundreds of thousands of patients. To ensure safe and effective use in all those patents it is essential also to develop, at unprecedented speed, a means to provide frequently updated, optimal dosing information for all patient subgroups. Success will require immediate collaboration between drug developers, academics, and regulators.
Cite
CITATION STYLE
Peck, R. W., Weiner, D., Cook, J., & Robert Powell, J. (2020). A Real-World Evidence Framework for Optimizing Dosing in All Patients With COVID-19. Clinical Pharmacology and Therapeutics, 108(5), 921–923. https://doi.org/10.1002/cpt.1922
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
